journal article·2022-03-29Open access

Influence of Amidation on the Release Profiles of Insulin Drug from Chitosan-Based Matrices

Wasmia Mohammed Dahan, Faruq Mohammad, Abdelrahman O. Ezzat, Ayman M. Atta, Hissah Hamad Al-Tilasi, Hamad A. Al-Lohedan

Coatings· Volume 12· Issue 4

Abstract

The present study deals with the comparative analysis of insulin drug release from pure chitosan (CS) and its crosslinked amide derivatives. The objective of this study was to investigate the influence of fatty acid derivatives on the release profiles of insulin drug from CS-based matrices. In order to form cross-linked CS-based amide derivatives, the CS biopolymer was reacted with four different fatty acids with varying amount of unsaturation, including stearic acid (SA), oleic acid (OA), linoleic acid (LA), and linolenic acid (LLA), and then subjected to cross-linking. Following this, the pure CS and cross-linked CS amide derivatives were loaded with insulin drug and were characterized thoroughly by making use of various instrumental techniques such as FTIR, UV–Vis, TGA, HRTEM, DLS, PDI, and zeta potential studies. In addition, the insulin release profiles were studied and compared between pure CS and CS amides at two different pHs, 7.4 and 1.2. Finally, the insulin drug release data was investigated with five different pharmacokinetic models (zero, first, Higuchi, Kersmeyer–Peppas, and Hixson models). From the analysis, the cross-linked CS amides was found to be superior to pure CS, and within the amide derivatives, the one with a high amount of unsaturation, LLA-derived CS biopolymer, was shown to be better for the release of insulin drug by means of the diffusion and dissolution pathways.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Nanocomposite Films for Food Packaging · Surfactants and Colloidal Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Chemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia

Funding

King Saud University

References (28)

Show source-provided references
1. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 204510.1016/j.diabres.2021.109119 ↗
2. Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay/glycol chitosan/Eudragit® S10010.1186/s12951-020-00662-x ↗
3. Mechanisms controlling pancreatic islet cell function in insulin secretion10.1038/s41580-020-00317-7 ↗
4. Insulin structure, function and diabetes models in animals10.5606/jebms.2020.75622 ↗
5. Cranston, R. (2020). Introduction 1. European Banking Law: The Banker-Customer Relationship, Taylor & Francis Group. [2nd ed.].10.4324/9781003123224 ↗
6. Formulation and characterisation of insulin-loaded chitosan nanoparticles capable of inducing glucose uptake in skeletal muscle cells in vitro10.1016/j.jddst.2020.101738 ↗
7. Emerging micro- and nanotechnology based synthetic approaches for insulin delivery10.1039/c3cs60436e ↗
8. Chitosan: A promising therapeutic agent and effective drug delivery system in managing diabetes mellitus10.1016/j.carbpol.2020.116594 ↗
9. Can natural polymers assist in delivering insulin orally?10.1016/j.ijbiomac.2017.05.138 ↗
10. Chitosan-based self-assembled nanomaterials: Their application in drug delivery10.1002/VIW.20200069 ↗
11. A review on potential anti-diabetic mechanisms of chitosan and its derivatives
12. An overview of the chemical modifications of chitosan and their advantages10.1680/jgrma.18.00053 ↗
13. de Sousa Victor, R., Marcelo da Cunha Santos, A., Viana de Sousa, B., de Araújo Neves, G., Navarro de Lima Santana, L., and Rodrigues Menezes, R. (2020). A review on Chitosan’s uses as biomaterial: Tissue engineering, drug delivery systems and cancer treatment. Materials, 13.10.3390/ma13214995 ↗
14. Potential of chitosan and its derivatives for controlled drug release applications—A review10.1016/j.jddst.2018.10.020 ↗
15. Mikušová, V., and Mikuš, P. (2021). Advances in chitosan-based nanoparticles for drug delivery. Int. J. Mol. Sci., 22.10.3390/ijms22179652 ↗
16. Synthesis and characterization of fatty acid grafted chitosan polymer and their nanomicelles for nonviral gene delivery applications10.1021/acs.bioconjchem.7b00505 ↗
17. Synthesis, characterization and functional properties of galactosylated derivatives of chitosan through amide formation Ana I. Ruiz Matute10.1016/j.foodhyd.2013.03.016 ↗
18. Synthesis and characterization of an amphiphilic linoleic acid-g-quaternary chitosan with low toxicity10.1155/2015/568925 ↗
19. Fatty acid and quaternary ammonium modified chitosan nanoparticles for insulin delivery10.1016/j.colsurfb.2018.05.063 ↗
20. Chemical modification of chitosan with fatty acids
21. Synthesis of silver nanoparticles by green method stabilized to synthetic human stomach fluid10.3390/molecules19056737 ↗
22. Dextran-crosslinked glucose responsive nanogels with a self-regulated insulin release at physiological conditions10.1016/j.eurpolymj.2020.109505 ↗
23. Insulin-loaded polymeric mucoadhesive nanoparticles: Development, characterization and cytotoxicity evaluation10.1590/s2175-97902018000117314 ↗
24. Manan, F.A.A., Yusof, N.A., Abdullah, J., Mohammad, F., Nurdin, A., Yazan, L.S., Khiste, S.K., and Al-Lohedan, H.A. (2021). Drug release profiles of mitomycin c encapsulated quantum dots–chitosan nanocarrier system for the possible treatment of non-muscle invasive bladder cancer. Pharmaceutics, 13.10.3390/pharmaceutics13091379 ↗
25. Barbosa, F.C., Silva, M.C.D., Silva, H.N.D., Albuquerque, D., Gomes, A.A.R., Silva, S.M.D.L., and Fook, M.V.L. (2020). Progress in the development of chitosan based insulin delivery systems: A systematic literature review. Polymers, 12.10.3390/polym12112499 ↗
26. In vitro and in vivo evaluation of thermosensitive chitosan hydrogel for sustained release of insulin10.3109/10717544.2014.932861 ↗
27. Ultrasound-triggered noninvasive regulation of blood glucose levels using microgels integrated with insulin nanocapsules10.1007/s12274-017-1500-z ↗
28. Polyurethane-incorporated chitosan/alginate core–shell nano-particles for controlled oral insulin delivery10.1002/app.46365 ↗